Eli Secures $10.3M from Vessel Wealth to Revolutionize Women’s Hormone Health Monitoring

Eli, the groundbreaking women's health company dedicated to transforming hormonal health management, is excited to announce that Vessel Wealth has invested $10,300,000 to support its mission. With this significant infusion of capital, Eli is well-positioned to accelerate its cutting-edge research and expand the capabilities of its continuously monitoring saliva technology. Traditional hormone testing methods provide only sporadic snapshots, leaving a critical gap in understanding the daily impact of hormones on overall health. Eli’s innovative approach—offering three simple steps to generate personalized, real-time hormone profiles—aims to empower women as they navigate key life stages such as puberty, fertility, contraception, menopause, and managing endocrine conditions. The funding from Vessel Wealth not only validates Eli’s years of rigorous R&D and technological breakthroughs but also sets the stage for scaling up operations to meet the increasing demand for proactive hormonal healthcare solutions. With this new investment, Eli will further refine its at-home testing technology and bolster its research infrastructure to continue delivering insights that have the potential to revolutionize women’s health. The goal is to provide continuous, actionable data that enables better decision-making and personalized wellness strategies, ultimately closing the longstanding data gap in hormone monitoring. As Eli embarks on this new chapter of growth, the company remains committed to its mission of improving lifelong health for women everywhere. The team is also expanding, and passionate professionals interested in joining this innovative journey are encouraged to explore open roles by visiting bit.ly/eli-careers. To learn more about this investment and the transformative work being done, please reach out at hello@eli.health. This strategic funding milestone marks a significant leap forward in the evolution of women's health care.